KANUMA
KANUMA
Approved
DIN Number
02469596
Drug Class
Human
Market Date
Apr 5, 2018
Company
HC
Alexion Pharma GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02469596
AIG Number0159670001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A16AB14 SEBELIPASE ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SEBELIPASE ALFAActive
Strength: 2 MG / ML
Monograph: SEBELIPASE ALFA